InnovAge Holding Corp. Operating Lease, Expense
InnovAge Holding Corp. (INNV) reported Operating Lease, Expense of $6.86 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-09-09
- InnovAge Holding Corp. operating lease, expense for the quarter ending 2026-06-30 was $2.26M, a 39.06% increase year-over-year.
- InnovAge Holding Corp. operating lease, expense for the quarter ending 2026-03-31 was $1.52M, a 6.50% decline year-over-year.
- InnovAge Holding Corp. operating lease, expense for the quarter ending 2025-12-31 was $1.52M, a 1.24% decline year-over-year.
- InnovAge Holding Corp. operating lease, expense for the quarter ending 2025-09-30 was $1.56M, a 0.64% decline year-over-year.
- InnovAge Holding Corp. operating lease, expense for fiscal 2026 was $6.86M, a 7.84% increase from fiscal 2025.
- InnovAge Holding Corp. operating lease, expense for fiscal 2025 was $6.36M, a 19.14% increase from fiscal 2024.
- InnovAge Holding Corp. operating lease, expense for fiscal 2024 was $5.34M, a 15.96% increase from fiscal 2023.
- InnovAge Holding Corp. operating lease, expense for fiscal 2023 was $4.60M.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $3.78M derived: sum of 2 quarters · filed 2026-09-09 | $5.30M derived: sum of 3 quarters · filed 2026-09-09 | $6.86M 10-K · filed 2026-09-09 |
| 2026-03-31 | $1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | $3.04M derived: sum of 2 quarters · filed 2026-05-08 | $4.60M 10-Q · filed 2026-05-08 | $6.23M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-12-31 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $3.08M 10-Q · filed 2026-02-03 | $4.70M derived: sum of 3 quarters · filed 2026-09-09 | $6.33M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-09-30 | $1.56M 10-Q · filed 2025-11-04 | $3.19M derived: sum of 2 quarters · filed 2026-09-09 | $4.82M derived: sum of 3 quarters · filed 2026-09-09 | $6.35M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-06-30 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $3.25M derived: sum of 2 quarters · filed 2026-09-09 | $4.79M derived: sum of 3 quarters · filed 2026-09-09 | $6.36M 10-K · filed 2026-09-09 |
| 2025-03-31 | $1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | $3.17M derived: sum of 2 quarters · filed 2026-05-08 | $4.74M 10-Q · filed 2026-05-08 | $6.25M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $1.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $3.11M 10-Q · filed 2026-02-03 | $4.62M derived: sum of 3 quarters · filed 2026-02-03 | $6.10M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | $1.57M 10-Q · filed 2025-11-04 | $3.08M derived: sum of 2 quarters · filed 2025-11-04 | $4.57M derived: sum of 3 quarters · filed 2025-11-04 | $5.81M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | $2.99M derived: sum of 2 quarters · filed 2025-09-09 | $4.24M derived: sum of 3 quarters · filed 2025-09-09 | $5.34M 10-K · filed 2025-09-09 |
| 2024-03-31 | $1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-06 | $2.73M derived: sum of 2 quarters · filed 2025-05-06 | $3.83M 10-Q · filed 2025-05-06 | $4.93M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-04 | $2.35M 10-Q · filed 2025-02-04 | $3.45M derived: sum of 3 quarters · filed 2025-02-04 | $4.62M derived: sum of 4 quarters · filed 2025-02-04 |
| 2023-09-30 | $1.10M 10-Q · filed 2024-11-05 | $2.21M derived: sum of 2 quarters · filed 2024-11-05 | $3.37M derived: sum of 3 quarters · filed 2024-11-05 | $4.95M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | $2.27M derived: sum of 2 quarters · filed 2024-09-10 | $3.84M derived: sum of 3 quarters · filed 2024-09-10 | $4.60M 10-K · filed 2024-09-10 |
| 2023-03-31 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-07 | $2.74M derived: sum of 2 quarters · filed 2024-05-07 | $3.50M 10-Q · filed 2024-05-07 | $3.50M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-06 | $2.33M 10-Q · filed 2024-02-06 | $2.33M derived: sum of 3 quarters · filed 2024-02-06 | |
| 2022-09-30 | $761.00K 10-Q · filed 2023-11-07 | $761.00K derived: sum of 2 quarters · filed 2023-11-07 | ||
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | $0.00 10-K · filed 2023-09-12 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |